Search

Author/Creator Aki, Anri

1. Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T‐cell and mast cell activation. Issue 8 (8th July 2020)

Authors:
Aki, Anri; Tanaka, Kento; Nagaoka, Nobumi; Kimura, Takako; Baba, Daichi; Onodera, Yoshikuni; Wada, Teiji; Maeda, Hiroaki; Nakanishi, Toshiyuki; Agatsuma, Toshinori; Komai, Tomoaki
Journal:
FASEB bioAdvances
Issue:
Volume 2:Issue 8(2020)
Page Start:
478
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4, 6-disubstituted indazole derivatives. Issue 23 (1st December 2017)

Authors:
Fukuda, Takeshi; Goto, Riki; Kiho, Toshihiro; Ueda, Kenjiro; Muramatsu, Sumie; Hashimoto, Masami; Aki, Anri; Watanabe, Kengo; Tanaka, Naoki
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 27:Issue 23(2017)
Page Start:
5252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives. Issue 20 (1st November 2018)

Authors:
Fukuda, Takeshi; Ishiyama, Takashi; Katagiri, Takahiro; Ueda, Kenjiro; Muramatsu, Sumie; Hashimoto, Masami; Aki, Anri; Baba, Daichi; Watanabe, Kengo; Tanaka, Naoki
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 28:Issue 20(2018)
Page Start:
3333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗